186 related articles for article (PubMed ID: 21931165)
1. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells.
Zhao Y; Thornton AM; Kinney MC; Ma CA; Spinner JJ; Fuss IJ; Shevach EM; Jain A
J Biol Chem; 2011 Nov; 286(47):40520-30. PubMed ID: 21931165
[TBL] [Abstract][Full Text] [Related]
2. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
4. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling.
Lee AJ; Wu X; Cheng H; Zhou X; Cheng X; Sun SC
J Biol Chem; 2010 May; 285(21):15696-703. PubMed ID: 20233721
[TBL] [Abstract][Full Text] [Related]
5. PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.
Thuille N; Wachowicz K; Hermann-Kleiter N; Kaminski S; Fresser F; Lutz-Nicoladoni C; Leitges M; Thome M; Massoumi R; Baier G
PLoS One; 2013; 8(1):e53709. PubMed ID: 23335970
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.
Reiley WW; Jin W; Lee AJ; Wright A; Wu X; Tewalt EF; Leonard TO; Norbury CC; Fitzpatrick L; Zhang M; Sun SC
J Exp Med; 2007 Jun; 204(6):1475-85. PubMed ID: 17548520
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
8. Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation.
Hasan M; Neumann B; Haupeltshofer S; Stahlke S; Fantini MC; Angstwurm K; Bogdahn U; Kleiter I
Immunol Cell Biol; 2015 Aug; 93(7):662-72. PubMed ID: 25823994
[TBL] [Abstract][Full Text] [Related]
9. Serum response factor controls CYLD expression via MAPK signaling pathway.
Liang G; Ahlqvist K; Pannem R; Posern G; Massoumi R
PLoS One; 2011 May; 6(5):e19613. PubMed ID: 21573132
[TBL] [Abstract][Full Text] [Related]
10. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
11. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor CYLD controls the function of murine regulatory T cells.
Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling.
Koga T; Lim JH; Jono H; Ha UH; Xu H; Ishinaga H; Morino S; Xu X; Yan C; Kai H; Li JD
J Biol Chem; 2008 May; 283(18):12546-54. PubMed ID: 18332137
[TBL] [Abstract][Full Text] [Related]
14. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.
Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G
Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464
[TBL] [Abstract][Full Text] [Related]
15. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
[TBL] [Abstract][Full Text] [Related]
16. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation.
Ahmed N; Zeng M; Sinha I; Polin L; Wei WZ; Rathinam C; Flavell R; Massoumi R; Venuprasad K
Nat Immunol; 2011 Nov; 12(12):1176-83. PubMed ID: 22057290
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinase CYLD controls protective immunity against helminth infection by regulation of Treg cell plasticity.
Lee JH; Zou L; Yang R; Han J; Wan Q; Zhang X; El Baghdady S; Roman A; Elly C; Jin HS; Park Y; Croft M; Liu YC
J Allergy Clin Immunol; 2021 Jul; 148(1):209-224.e9. PubMed ID: 33309741
[TBL] [Abstract][Full Text] [Related]
18. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
Moquin DM; McQuade T; Chan FK
PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
[TBL] [Abstract][Full Text] [Related]
19. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2017 May; 18(5):797-808. PubMed ID: 28381482
[TBL] [Abstract][Full Text] [Related]
20. TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation.
Kurebayashi Y; Baba Y; Minowa A; Nadya NA; Azuma M; Yoshimura A; Koyasu S; Nagai S
Biochem Biophys Res Commun; 2016 Nov; 480(1):114-119. PubMed ID: 27697523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
